Literature DB >> 10566767

Anaphylactic reaction to oxaliplatin: a case report.

I Larzillière, S Brandissou, P Breton, A Lingoungou, D Gargot, J P Ramain, C Harnois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10566767     DOI： 10.1111/j.1572-0241.1999.3387a.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: a Japanese experience.

Authors:  Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eiji Oki; Ken Shirabe; Tetsuo Toyama; Takefumi Ohga; Manabu Yamamoto; Hirofumi Hasegawa; Fumiko Kohakura; Hidefumi Higashi; Kiyoshi Niwa; Fumihiko Fujita; Yutaka Ogata; Shunji Kohnoe; Masafumi Inomata; Hironori Samura; Shoji Tokunaga; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

Review 2.  Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.

Authors:  Ming-Yang Lee; Muh-Hwa Yang; Jin-Hwang Liu; Chueh-Chuan Yen; Pang-Chan Lin; Hao-Wei Teng; Wei-Shu Wang; Tzeon-Jye Chiou; Po-Min Chen
Journal:  Support Care Cancer       Date:  2006-07-25       Impact factor: 3.603

Review 3.  Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

Authors:  Jui-Ho Wang; Tai-Ming King; Min-Chi Chang; Chao-Wen Hsu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

4.  Hypersensitivity reactions related to oxaliplatin (OHP).

Authors:  G Brandi; M A Pantaleo; C Galli; A Falcone; A Antonuzzo; P Mordenti; M C Di Marco; G Biasco
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.